Company / R&D per Share
Phio Pharmaceuticals Corp. R&D per Share History
FY2012-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$6.42
FY2020
5-year range
$1.06 / $12.63
FY2016-FY2020
Trend
-49.1%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D per Share has fluctuated over the past 7 years, ranging from $0.07 in FY2012 to $12.63 in FY2019.
Based on SEC 10-K filings.
6.42 in FY2020 with a 3-year CAGR of +15.5%.
Improved from $2.21 to $6.42 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +15.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, r&d per share decreased 49.1% year-over-year.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2012.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $6.42 | -49.1% |
| FY2019 | $12.63 | +471.4% |
| FY2018 | $2.21 | -46.9% |
| FY2017 | $4.16 | +293.0% |
| FY2016 | $1.06 | -46.4% |
| FY2013 | $1.98 | +2896.2% |
| FY2012 | $0.07 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026